Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.002 |
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.003 |
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.091 | 0.005 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |